Ditchcarbon
  • Customers
  1. Organizations
  2. Tris Pharma, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Tris Pharma, Inc.

Company website

Tris Pharma, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in developing innovative drug delivery systems, particularly in the areas of paediatrics and chronic pain management. Tris Pharma focuses on creating unique formulations that enhance patient compliance and therapeutic outcomes, setting it apart from competitors. With a strong presence in the US market, Tris Pharma has achieved significant milestones, including the successful launch of several proprietary products that address unmet medical needs. The company’s commitment to research and development, coupled with its expertise in complex formulations, has solidified its position as a trusted partner in the pharmaceutical landscape.

DitchCarbon Score

How does Tris Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Tris Pharma, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Tris Pharma, Inc.'s reported carbon emissions

Tris Pharma, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Tris Pharma may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company does not inherit emissions data from any parent or related organisations, nor does it participate in recognised climate frameworks like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Tris Pharma, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Tris Pharma, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Tris Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Eurand, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

PHH Home Loans, LLC

US
•
Financial intermediation services, except insurance and pension funding services (65)
Updated 13 days ago

Rhodes Pharmaceuticals LP

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Purdue Pharma L.P.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Corium, LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Assertio Holdings, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy